Back to Search
Start Over
Non-pharmacological treatment of refractory angina: The coronary sinus reducer, the new kid on the block.
- Source :
-
Revista portuguesa de cardiologia [Rev Port Cardiol (Engl Ed)] 2021 May; Vol. 40 (5), pp. 371-382. Date of Electronic Publication: 2021 Apr 06. - Publication Year :
- 2021
-
Abstract
- Refractory angina is defined as persistent angina (≥3 months) despite optimal medical and interventional therapies. It is increasing in frequency, due to the success of current medical and interventional therapies in improving the prognosis of coronary artery disease. Long-term mortality is similar to that of patients with asymptomatic stable disease, but it affects patients' quality of life, and has a significant impact on health care resources. Several therapeutic targets have been investigated, most with disappointing results. Many of the techniques have been abandoned because of lack of efficacy, safety issues, or economic and logistic limitations to wider applicability. The primary focus of this review is the coronary sinus Reducer, supporting evidence for which, although scarce, is promising regarding safety and efficacy in improving anginal symptoms and quality of life. It is also accessible to virtually all interventional cardiology departments.<br /> (Copyright © 2021 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 2174-2049
- Volume :
- 40
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Revista portuguesa de cardiologia
- Publication Type :
- Academic Journal
- Accession number :
- 34187640
- Full Text :
- https://doi.org/10.1016/j.repce.2020.09.003